Acrivon Therapeutics Inc
ACRV1.300USD
+0.040+3.17%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
40.76MMarket Cap
LossP/E TTM
Acrivon Therapeutics Inc
1.300
+0.040+3.17%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
Total equity
Cash, cash equivalents and short-term investments
36.06%149.63M
40.82%179.48M
31.93%187.45M
19.60%180.54M
-8.52%109.97M
-0.23%127.46M
84.96%142.09M
80.01%150.95M
--120.21M
--127.75M
--76.82M
--83.86M
- Cash and cash equivalents
59.12%39.15M
10.56%39.82M
45.40%43.41M
20.83%46.01M
-10.48%24.61M
22.01%36.02M
-6.92%29.86M
-54.60%38.07M
--27.49M
--29.52M
--32.08M
--83.86M
-Short-term investments
29.42%110.48M
52.73%139.66M
28.34%144.04M
19.18%134.53M
-7.93%85.37M
-6.91%91.44M
150.83%112.23M
--112.88M
--92.72M
--98.23M
--44.74M
----
Prepaid expenses
-21.96%1.69M
-3.80%2.15M
-36.26%1.53M
-21.78%1.82M
-42.20%2.17M
-48.57%2.23M
29.91%2.40M
-29.48%2.33M
--3.75M
--4.34M
--1.85M
--3.30M
Total current assets
34.94%151.33M
40.05%181.63M
30.79%188.98M
18.97%182.36M
-9.54%112.14M
-1.82%129.69M
83.66%144.49M
75.86%153.28M
--123.96M
--132.09M
--78.67M
--87.16M
Non-current assets
Net Fixed Assets
4.85%7.98M
1.48%8.03M
36.81%8.47M
17.05%7.44M
15.86%7.61M
15.24%7.91M
-12.94%6.19M
-11.95%6.36M
--6.57M
--6.86M
--7.11M
--7.22M
-Fixed Assets
16.63%10.26M
12.67%9.99M
44.74%10.13M
25.85%8.85M
23.57%8.79M
21.72%8.86M
-5.51%7.00M
-4.97%7.03M
--7.12M
--7.28M
--7.40M
--7.40M
-Accumulated depreciation
92.63%2.27M
105.23%1.96M
105.58%1.66M
108.90%1.41M
116.51%1.18M
127.62%956.00K
173.56%807.00K
276.54%674.00K
--545.00K
--420.00K
--295.00K
--179.00K
Other non-current assets
141.18%1.84M
177.44%1.84M
348.42%1.84M
117.89%889.00K
97.16%765.00K
71.39%665.00K
-78.73%411.00K
-33.33%408.00K
--388.00K
--388.00K
--1.93M
--612.00K
Total non-current assets
198.66%25.02M
74.49%14.96M
289.39%25.70M
612.68%48.23M
-81.88%8.38M
-82.55%8.57M
-27.00%6.60M
-13.62%6.77M
--46.23M
--49.13M
--9.04M
--7.83M
Total assets
46.32%176.35M
42.18%196.59M
42.09%214.68M
44.07%230.59M
-29.19%120.52M
-23.71%138.26M
72.26%151.09M
68.48%160.05M
--170.20M
--181.23M
--87.71M
--95.00M
Liabilities
Current liabilities
-Other payables
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
--0.00
--69.00K
--0.00
--0.00
Accrued expenses
44.91%8.75M
108.72%15.40M
74.85%12.27M
81.01%9.04M
69.31%6.04M
53.17%7.38M
89.81%7.02M
170.99%5.00M
--3.57M
--4.82M
--3.70M
--1.84M
Other current liabilities
----
----
----
----
----
-100.00%0.00
--0.00
--0.00
--0.00
--69.00K
--0.00
--0.00
Total current liabilities
49.87%13.55M
29.40%17.21M
59.36%14.82M
60.81%11.28M
59.12%9.04M
104.16%13.30M
45.50%9.30M
57.61%7.02M
--5.68M
--6.52M
--6.39M
--4.45M
Non-current liabilities
Long-term debt and lease liabilities
-31.19%2.41M
-31.30%2.59M
-18.41%2.97M
-15.72%3.24M
-13.47%3.50M
-11.05%3.77M
-17.56%3.64M
-16.38%3.85M
--4.05M
--4.24M
--4.42M
--4.60M
-Long-term lease liabilities
-31.19%2.41M
-31.30%2.59M
-18.41%2.97M
-15.72%3.24M
-13.47%3.50M
-11.05%3.77M
-17.56%3.64M
-16.38%3.85M
--4.05M
--4.24M
--4.42M
--4.60M
Total non-current liabilities
-31.19%2.41M
-31.30%2.59M
-18.41%2.97M
-15.72%3.24M
-13.47%3.50M
-11.05%3.77M
-17.56%3.64M
-16.38%3.85M
--4.05M
--4.24M
--4.42M
--4.60M
Total liabilities
27.24%15.96M
16.00%19.80M
37.46%17.79M
33.70%14.53M
28.93%12.54M
58.78%17.07M
19.72%12.94M
20.00%10.87M
--9.73M
--10.75M
--10.81M
--9.05M
Shareholders' equity
Common equity
56.36%376.76M
57.05%373.31M
57.14%370.25M
58.31%367.78M
5.11%240.96M
4.90%237.70M
14444.38%235.62M
17380.29%232.31M
--229.25M
--226.60M
--1.62M
--1.33M
Preferred equity
----
----
----
----
----
----
----
----
----
----
--122.52M
--122.52M
Retained earnings
-63.01%-216.66M
-69.19%-196.98M
-79.22%-174.15M
-83.43%-151.70M
-93.21%-132.91M
-107.77%-116.42M
-106.29%-97.17M
-118.18%-82.70M
---68.79M
---56.03M
---47.10M
---37.91M
Capital reserves
56.36%376.73M
57.06%373.28M
57.14%370.22M
58.31%367.75M
5.11%240.93M
4.90%237.68M
14461.00%235.60M
17431.40%232.29M
--229.23M
--226.58M
--1.62M
--1.32M
Gains losses not affecting retained earnings
504.29%283.00K
638.55%447.00K
358.94%782.00K
95.55%-19.00K
-877.78%-70.00K
12.63%-83.00K
-127.07%-302.00K
---427.00K
--9.00K
---95.00K
---133.00K
----
Total equity
48.54%160.39M
45.87%176.79M
42.52%196.89M
44.83%216.06M
-32.71%107.98M
-28.91%121.19M
79.64%138.15M
73.59%149.18M
--160.47M
--170.47M
--76.90M
--85.94M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
